BTIG Continues Expansion of Investment Banking Unit with Senior Hires

NEW YORK–(BUSINESS WIRE)–BTIG announced today that over the last year its Investment Banking unit has experienced significant growth. With an increase in its deal flow and banking activity, the firm continues to recruit sector and product-focused bankers to service the needs of a growing corporate client segment. Some of BTIG’s key additions include Corey Davis, Gautam Garg, Karen Koski, Colin LeStrange, Glenn Medwar and Dan Shea, who will each focus on structuring and originating transactions across their respective sectors and product lines.

BTIG’s Investment Banking effort continues to gain traction in facilitating advisory services for growth-oriented companies. This continued growth follows a successful launch of the firm’s Mergers and Acquisitions platform in January 2019. In the last two years, BTIG has executed more than 160 transactions across the consumer, energy, financials, healthcare, real estate, and technology, media and telecommunications (TMT) sectors. So far in 2019, BTIG also closed 60-plus transactions, serving as a bookrunner or lead manager in 25% of its capital markets transactions. Assignments varied across equity and debt capital markets, M&A and strategic advisory.

“BTIG continues to bolster our investment banking platform and coverage teams with experienced professionals, who will advance our deal origination pipeline,” noted Charles Mather, CFA, Co-Head of Equity Capital Markets and Head of Capital Markets Origination. “Since joining the firm, Corey, Gautam, Karen, Colin, Glenn and Dan have initiated important discussions with key prospects, and we look forward to their future contributions.”

Mr. Davis is a Managing Director within TMT Investment Banking at BTIG in San Francisco, focused on the fintech vertical. Prior to BTIG, he led the Banking and Payments, Insurtech and Fixed Income coverage at SenaHill Partners. Mr. Davis has more than 20 years of transactional experience and specializes in M&A and capital raising within the financial services sector. He earned a BS in finance with distinction from Georgetown University, and an MBA from Harvard Business School.

Mr. Garg is a Director within BTIG’s Investment Banking team in San Francisco, focused on mergers and acquisitions. Prior to BTIG, he was a Director of Investment Banking at GCA. Previously, Mr. Garg was a Director of Global Pricing Strategy at Oracle Corporation. He earned a BS and an MS in electrical and computer engineering, both from Carnegie Mellon University, and an MBA from the University of California, Berkeley.

Ms. Koski is a Managing Director within Healthcare Investment Banking at BTIG in Boston, focused on medical devices, life sciences tools and diagnostics companies. Prior to joining BTIG Investment Banking, she was Vice President of Strategy and Investor Relations at Oxford Immunotec. Previously, Ms. Koski spent several years in healthcare equity research, including a role as a Director at BTIG, where she was named an All-America Research Team Rising Star by Institutional Investor in 2016 for her coverage of life science and diagnostic tools. She earned a BS in medical technology from the University of Vermont.

Mr. LeStrange is a Director within TMT Investment Banking at BTIG in New York. Prior to BTIG, he was a Vice President within Technology Investment Banking at Alantra. Previously, Mr. LeStrange co-founded and sold HireOwl, an HR technology company. Mr. LeStrange earned a BBA in international business from Loyola University.

Mr. Medwar is a Managing Director within BTIG’s Investment Banking team in New York, focused on Debt Capital Markets. Prior to BTIG, he was a Managing Director and Head of Leveraged Finance at Mizuho Securities. Previously, Mr. Medwar held senior roles within Financial Sponsors and Leveraged Finance at Credit Suisse and Lehman Brothers. He earned an MBA from the MIT Sloan School of Management and a BS in civil and environmental engineering from the University of Massachusetts, Amherst.

Mr. Shea is a Managing Director within Consumer Investment Banking at BTIG in New York. Prior to BTIG, he was a Managing Director at Keen-Summit Capital Partners. Mr. Shea held similar roles at Canaccord Genuity, Sterne Agee-CRT and Janney Montgomery Scott. He earned his MBA from UCLA and a BS from Georgetown University.

“At BTIG, we continue to recruit bankers, who are committed to helping clients achieve their objectives,” added Mr. Mather. “We believe the broad network of relationships and expertise of these hires will help our TMT, M&A, healthcare, consumer and debt capital markets clients excel and hit important milestones in their corporate stories.”

BTIG’s investment banking products include mergers and acquisitions, capital markets advisory, IPOs, follow-on offerings, ATMs, SPACs, private placements, convertibles, debt, buybacks, liquidity solutions, venture capital, private equity and private capital. Clients benefit from proprietary and actionable market intelligence, and BTIG’s comprehensive understanding of financial dynamics. Aftermarket services include trading coverage and corporate access, connecting issuers with the buy side.

About BTIG

BTIG is a global financial services firm specializing in institutional trading, investment banking, research and related brokerage services. With an extensive global footprint and more than 600 employees, BTIG, LLC and its affiliates operate out of 18 cities throughout the U.S., and in Europe, Asia and Australia. BTIG offers execution, expertise and insights for equities, equity derivatives, ETFs and fixed income, currency and commodities (futures, commodities, foreign exchange, interest rates, credit, and convertible and preferred securities). The firm’s core capabilities include global execution, portfolio, electronic and outsource trading, transition management, investment banking, prime brokerage, capital introduction, corporate access, research and strategy, commission management and more.

Disclaimer: https://www.btig.com/disclaimer. To learn more about BTIG, visit www.btig.com.

Contacts

Jill Gordon

646.818.9226

jgordon@prosek.com

Amanda Gold

212.738.6134

agold@btig.com

Staff

Recent Posts

HeartBeam to Attend JP Morgan 2025 Annual Healthcare Conference

HeartBeam system was recently cleared by US Food and Drug Administration (FDA) for comprehensive arrhythmia…

2 hours ago

Glaukos Submits New Drug Application to U.S. FDA for Epioxa™

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused…

2 hours ago

The National Children’s Cancer Society Awarded $1,000 Grant From Kars4Kids

This generous grant will directly benefit the NCCS's Beyond the Cure Ambassador Scholarship Program, which…

2 hours ago

Honeycomb Clinic Positions for Public Offering

Medical Co-working space challenges broken healthcare system. HOUSTON, TEXAS / ACCESSWIRE / December 23, 2024…

2 hours ago

Ensysce Biosciences Regains Full Compliance with Nasdaq

SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce"…

2 hours ago